Health Canada Approves 4Moving Biotech’s Knee Osteoarthritis Trial
Health Canada’s approval enables 4Moving Biotech to initiate the INFLAM MOTION Phase 2a clinical trial 4Moving Biotech , a spin-off of 4P-Pharma dedicated to developing first-in-class treatment that modify...